Order PathwayBio panels for your patients to inform treatment decisions with objective immune pathway data.
Move beyond trial-and-error with objective immune pathway data to guide biologic/DMT selection.
Help patients avoid months on ineffective medications by starting with pathway-matched treatments.
Receive detailed, physician-friendly reports with pathway analysis and treatment recommendations.
Identify patients who may benefit from cutting-edge trials based on their immune profiles.
All testing performed at CLIA-certified partner laboratories with rigorous quality standards.
Easy requisition process with patient-friendly specimen collection kits and prepaid shipping.
Download and complete the test requisition form with patient information and panel selection.
Patient receives collection kit at home or visits local lab for blood draw. Prepaid shipping included.
Specimens processed at CLIA-certified partner lab. Results available in 10-14 business days.
Both you and your patient receive comprehensive reports via secure portal. Discuss findings at next visit.
Order CrohnProfile™ for patients initiating biologic therapy or considering treatment escalation. Identifies IL-23, TNF-α, or mixed pathway dominance to inform selection of Skyrizi, Stelara, Humira, Remicade, or other agents.
Order MSProfileâ„¢ for newly diagnosed patients or those considering escalation to high-efficacy DMTs. Identifies Th1, Th17, or B-cell dominant pathways plus JC virus status for PML risk assessment.
Order HashiProfileâ„¢ for symptomatic patients despite levothyroxine therapy. IgG subtyping distinguishes active immune attack from burned-out disease to guide immune modulation strategies.
Contact us to discuss provider ordering and institutional partnerships
Contact Us →